US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
The Albanese Labor Government is building Australia’s future by investing in an expansion of Australia’s ons...
Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...
SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...
China's oncology firm Antengene Corporation has announced that the Indonesia National Agency of Drug and Food Control (B...
Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...
Taiwan-based Formosa Group Executive Committee member and Chairman Sandy Wang, who leads the group's bio and eco-friendl...
Avecho Biotechnology has signed an exclusive ten-year development and licensing agreement with Sandoz Group AG for the c...
Japan-based Shionogi & Co. has announced the conclusion of a comprehensive collaboration agreement with Osaka Metrop...
Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...
Over the past decade, interest in Antibody-Drug Conjugates (ADCs) has surged, driven by their promise for patients, adva...
The first Antibody-Drug Conjugate (ADC) prototypes were developed more than 55 years ago by researchers of the Institut ...
Can you share how the company’s focus has evolved since its founding, and what areas are central to Terumo's curre...
Soon after being sworn in as the 47th President of the United States, Donald Trump signed an Executive Order to withdraw...
Patent cliffs will be one of the originator's biggest pain points in the next 3-5 years. Between the originator and bios...
By 2030, pharmaceutical companies are expected to lose over $236 billion in revenue due to the impending ‘patent c...
Malaysia is facing a growing environmental and public health threat due to improper disposal of pharmaceutical wast...
Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...
MojiaBio, a leading innovator in green chemistry and sustainable biomanufacturing, will be developing an SGD 44.8 m...
Florricks Lifecare, a leading research-driven pharmaceutical company in India, involved in R&D, production, and sale...
“We made good progress in 2024, which was capped by a fourth quarter of strong topline growth driven by key produc...
"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance glob...
A Leading Center for Biopharma Excellence BIX has established itself as a must-attend event for professionals across th...
Israel-based CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologie...
FibroGen, Inc. has announced the sale of its China subsidiary to AstraZeneca for approximately $160 million. Under the t...
